The objective is to improve current diagnostics and to enable prevention-based approaches and to segregate patient populations (sub-typing) addressing the current responder/non-responder issues in Western medicine. The main objective is to discover novel biomarkers for two important chronic disease areas: type 2 diabetes and arthritis (osteoarthritis and rheumatoid arthritis).

Diagnostic discovery strategies will be based on “Disease phenotyping using metabolomics-based Systems Biology” and “ultra-weak photon emission”.